- Price
- $46.01
- Day
- -0.33%
- Mkt Cap
- $1.61B
- 52W Range
- $14.72 – $49.58
- Volume
- 690.0K
- Beta
- 3.37
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Shares of First Tracks Biotherapeutics (NASDAQ: TRAX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1-year price
Read full article